• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG DC BOULDER SILS PORT; LAPAROSCOPE, GENERAL & PLASTIC SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG DC BOULDER SILS PORT; LAPAROSCOPE, GENERAL & PLASTIC SURGERY Back to Search Results
Model Number SILSPT5
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Failure to Anastomose (1028); Infarction, Cerebral (1771); Sepsis (2067); Blood Loss (2597); Radiation Exposure, Unintended (3164); No Code Available (3191)
Event Date 02/01/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).A step toward notes total mesorectal excision for rectal cancer: endoscopic transanal proctectomy annals of surgery volume 261: 228¿233, number 2, february 2015.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to literature source of study performed from february 2010 to june 2012, previous publications have suggested that endoscopic transanal proctectomy (etap) is a promising technique and may be an alternative to conventional low anterior resection for rectal cancer.The aim of this study was to evaluate the technical feasibility of etap, using port devices.Fifty-six consecutive patients (41 men) underwent etap.The port was used in 11 cases; however, complications were not reported by a single-port device.The overall post-operative complication rate was 26% (14/56).Three patients developed a clinical anastomotic leakage that did not require reoperation.Three additional patients were diagnosed with pelvic sepsis without evidence of anastomotic leak (2 of them required drainage under ct scan), 5 patients experienced transient urinary disorders, 2 patients required red blood cell transfusion during the postoperative course, and a (b)(6)-year-old woman suffered from a cerebral infarction with a favorable outcome.The median hospital stay was 10 days.Article: jean-jacques tuech, 2015, annals of surgery volume 261, number 2.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SILS PORT
Type of Device
LAPAROSCOPE, GENERAL & PLASTIC SURGERY
Manufacturer (Section D)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer (Section G)
COVIDIEN MFG DC BOULDER
5920 longbow dr
boulder CO 80301 3299
Manufacturer Contact
lisa hernandez
60 middletown ave
north haven, CT 06473
2034925563
MDR Report Key10249732
MDR Text Key198082357
Report Number1717344-2020-00710
Device Sequence Number1
Product Code GCJ
UDI-Device Identifier10884523002638
UDI-Public10884523002638
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K093372
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Other
Type of Report Initial
Report Date 07/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberSILSPT5
Device Catalogue NumberSILSPT5
Was Device Available for Evaluation? No
Date Manufacturer Received06/20/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age65 YR
-
-